Data updated: Mar 29, 2026
TROXYCA ER
NALTREXONE HYDROCHLORIDE
Approved 2016-08-19
1
Indication
--
Phase 3 Trials
9
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2016-08-19
- Routes
- ORAL
- Dosage Forms
- CAPSULE, EXTENDED RELEASE
TROXYCA ER Approval History
Loading approval history...
What TROXYCA ER Treats
1 FDA approvalsOriginally approved for its first indication in 2016 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TROXYCA ER FDA Label Details
ProTROXYCA ER Patents & Exclusivity
Latest Patent: Dec 2027
Patents (36 active)
US7815934
Expires Dec 12, 2027
+ 26 more patents
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.